- Country: Finland
- Summary: Lot 2: Potassium Iodide 65 Mg
- FIT Ref No: 94623203
- Deadline: 30 Oct 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 583677-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the procurement is article in accordance with the following requirements: - The subject of tender: “Potassium iodide 65 mg” - Active pharmaceutical ingredient: Potassium iodide - Pharmaceutical form: tablets - Package size: 10 - 100 tablets in blisters or in bottles. The minimum requirements of the article is described in more detail in Annex 1.2. Estimated quantity for the article is described in Annex 5 (restricted, TLIV). The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Doc Title: LOT 2: Potassium iodide 65 mg
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLot 2: Potassium Iodide 65 Mg - Finland Tender
The FINNISH INSTITUE FOR HEALTH AND WELFARE, a Government sector organization in Finland, has announced a new tender for Lot 2: Potassium Iodide 65 Mg. This tender is published on FinlandTenders under FIT Ref No: 94623203 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-01-03.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
